Similar articles for PMID: 25879521

Year	Number of Results
1989	1
1991	1
1993	2
1994	2
1995	4
1996	2
1997	1
1998	1
1999	8
2000	17
2001	31
2002	21
2003	13
2004	12
2005	5
2006	15
2007	12
2008	9
2009	12
2010	10
2011	15
2012	20
2013	13
2014	14
2015	29
2016	26
2017	20
2018	9
2019	20
2020	15
2021	20
2022	6
2023	2
2024	0

1

Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Reimers LL, Sivasubramanian PS, Hershman D, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M, Crew KD. Reimers LL, et al. Breast J. 2015 Jul-Aug;21(4):377-86. doi: 10.1111/tbj.12418. Epub 2015 Apr 16. Breast J. 2015. PMID: 25879521 Free PMC article.

2

Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Trivedi MS, Coe AM, Vanegas A, Kukafka R, Crew KD. Trivedi MS, et al. Cancer Prev Res (Phila). 2017 Aug;10(8):434-441. doi: 10.1158/1940-6207.CAPR-17-0100. Epub 2017 Jun 13. Cancer Prev Res (Phila). 2017. PMID: 28611039 Free PMC article.

3

The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Wolmark N. Vogel VG, et al. Clin Breast Cancer. 2002 Jun;3(2):153-9. doi: 10.3816/CBC.2002.n.020. Clin Breast Cancer. 2002. PMID: 12123540 Clinical Trial.

4

Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention.

Vogel VG. Vogel VG. Curr Drug Targets. 2011 Dec;12(13):1874-87. doi: 10.2174/138945011798184164. Curr Drug Targets. 2011. PMID: 21158712 Review.

5

Chemoprevention of breast cancer: implications for postmenopausal women.

Fabian CJ, Kimler BF. Fabian CJ, et al. Drugs Aging. 2002;19(1):43-78. doi: 10.2165/00002512-200219010-00004. Drugs Aging. 2002. PMID: 11929326 Review.

6

Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.

Levine M, Moutquin JM, Walton R, Feightner J; Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Levine M, et al. CMAJ. 2001 Jun 12;164(12):1681-90. CMAJ. 2001. PMID: 11450210 Free PMC article. Review.

7

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.

US Preventive Services Task Force; Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Doubeni CA, Epling JW Jr, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Tseng CW, Wong JB. US Preventive Services Task Force, et al. JAMA. 2019 Sep 3;322(9):857-867. doi: 10.1001/jama.2019.11885. JAMA. 2019. PMID: 31479144

8

Chemoprevention of breast cancer.

Zelnak AB, O'Regan RM. Zelnak AB, et al. Curr Probl Cancer. 2004 Jul-Aug;28(4):201-17. doi: 10.1016/j.currproblcancer.2004.05.007. Curr Probl Cancer. 2004. PMID: 15318323 Review. No abstract available.

9

Chemoprevention of breast cancer: a summary of the evidence for the U.S. Preventive Services Task Force.

Kinsinger LS, Harris R, Woolf SH, Sox HC, Lohr KN. Kinsinger LS, et al. Ann Intern Med. 2002 Jul 2;137(1):59-69. doi: 10.7326/0003-4819-137-1-200207020-00017. Ann Intern Med. 2002. PMID: 12093250 Free article. Review.

10

Current concepts in breast cancer chemoprevention.

Chlebowski RT. Chlebowski RT. Pol Arch Med Wewn. 2014;124(4):191-9. doi: 10.20452/pamw.2190. Epub 2014 Mar 10. Pol Arch Med Wewn. 2014. PMID: 24618912 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

365 results

Results by year